Nuveen Asset Management, LLC Instil Bio, Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.48 - $5.33 $102,317 - $1.14 Million	-213,162 Reduced 91.89%	18,818 $12,000
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $12,494 - $19,803	-2,687 Reduced 1.15%	231,980 $1.12 Million
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $192,224 - $509,097	45,659 Added 24.16%	234,667 $1.09 Million
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $250,219 - $534,076	-29,507 Reduced 13.5%	189,008 $2 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $2.48 Million - $3.63 Million	161,292 Added 281.87%	218,515 $3.65 Million
Q3 2021 Nov 12, 2021	SELL	$15.05 - $23.28 $18,225 - $28,192	-1,211 Reduced 2.07%	57,223 $1.13 Million
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $894,624 - $1.44 Million	58,434 New	58,434 $1.13 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.